Acyclovir antiviral gel composition

Details Acyclovir antiviral gel composition Acyclovir antiviral gel composition

1993-12-28

1996-12-17

Wilson, James O.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514944, 514946, 514947, 424677, A61K 3152

Patent

active

055853790

ABSTRACT:
An antiviral topical pharmaceutical composition for treating viral diseases of the skin or mucosa comprises a poorly soluble antiviral nucleoside derivative, dispersed in an aqueous gel carrier containing a gelling agent and a water-soluble carboxylic or dicarboxylic acid salt.

REFERENCES:
patent: 4537776 (1985-08-01), Cooper
patent: 4956184 (1990-09-01), Kross
Toshinobu Seki et al., Enchanced Transdermal Delivery of Zidovudine in Rats and Human Skin, Chem. Pharm. Bull., vol. 38, No. 11, 1990 (pp. 3086-3089).
Toshinobu Seki et al., Percutaneous Absorption of Azidothyumidine in Rats, International Journal of Pharmaceutics, vol. 57, 1989 (pp. 73-75).

Affiliated with

Also associated with

Rating

Acyclovir antiviral gel composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acyclovir antiviral gel composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyclovir antiviral gel composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1991509